Author

R. Miyamoto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Kanai· 2 shared A. Yokoyama· 2 shared H. Matsui· 2 shared H. Okuda· 2 shared S. Takahashi· 2 shared T. Inaba· 2 shared A. Takaori-Kondo· 1 shared T. Kawamura· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Kanai

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivJan 8, 2021

HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis

S. Takahashi, A. Kanai, H. Okuda…·A. Yokoyama

This study identifies the HBO1-MLL interaction as critical for leukemogenesis by facilitating the AF4/ENL/P-TEFb complex-mediated gene activation in MLL fusion proteins.

DOI 10.7554/elife.65872

humanproteomics

Cancer BiologybioRxivOct 20, 2020

HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways

R. Miyamoto, A. Kanai, H. Okuda…·A. Yokoyama

This study shows HOXA9 promotes MYC-driven leukemogenesis by maintaining anti-apoptotic gene expression through multiple pathways.

DOI 10.7554/elife.64148

humanexperimental assay